William Waddill
Director/Board Member at ANNEXON, INC.
Net worth: 1 M $ as of 2024-04-29
Profile
Mr. William D.
Waddill, CPA, is an Independent Director at Turnstone Biologics Corp., an Independent Director at Annexon, Inc., an Independent Non-Executive Director at Arrowhead Pharmaceuticals, Inc. and an Independent Director at Protagonist Therapeutics, Inc. He is on the Board of Directors at Turnstone Biologics Corp., Annexon, Inc., Arrowhead Pharmaceuticals, Inc., Protagonist Therapeutics, Inc., Annexon Biosciences, Inc. and Protagonist Pty Ltd.
Mr. Waddill was previously employed as a Director-Emeritus by The Association of Bioscience Financial Officers, a Chief Financial Officer, Senior VP & Treasurer by Calithera Biosciences, Inc., a Chief Financial Officer, Treasurer & Senior VP by OncoMed Pharmaceuticals, Inc., a Chief Financial Officer & Senior Vice President by Ilypsa, Inc., a Principal by Square One Finance, a Principal by Square One Resources Ltd., a Senior Director-Finance & Administration by Exelixis, Inc., a Principal by Deloitte & Touche, Inc., a Chief Financial Officer by Medical Science Partners LP, and a Principal by PricewaterhouseCoopers LLP.
He also served on the board at Sorbent Therapeutics, Inc. and Biotechnology Innovation Organization.
He received his undergraduate degree from the University of Illinois.
Known holdings in public companies
| Company | Date | Number of shares | Valuation | Valuation date |
|---|---|---|---|---|
| 2024-01-10 | 47,870 ( 0.04% ) | 1 M $ | 2024-04-29 | |
| 2024-03-14 | 12,000 ( 0.02% ) | 295 920 $ | 2024-04-29 | |
ANNEXON, INC.
-.--% | 2024-02-29 | 0 ( -.--% ) | - $ | 2024-04-29 |
William Waddill active positions
| Companies | Position | Start |
|---|---|---|
| PROTAGONIST THERAPEUTICS, INC. | Director/Board Member | 2016-06-30 |
| ARROWHEAD PHARMACEUTICALS, INC. | Director/Board Member | 2017-12-31 |
| ANNEXON, INC. | Director/Board Member | 2021-08-11 |
| TURNSTONE BIOLOGICS CORP. | Director/Board Member | 2024-04-14 |
| Annexon Biosciences, Inc. | Director/Board Member | - |
Protagonist Pty Ltd.
 Protagonist Pty Ltd. Pharmaceuticals: MajorHealth Technology Protagonist Pty Ltd. operates as a clinical-stage biopharmaceutical company. Its proprietary technology platform focused on discovering and developing peptide-based new chemical entities to address significant unmet medical needs. The company was founded on September 19, 2001 and is headquartered in Brisbane, Australia. | Director/Board Member | - |
Former positions of William Waddill
| Companies | Position | End |
|---|---|---|
| CALITHERA BIOSCIENCES, INC. | Director of Finance/CFO | 2016-12-30 |
| ONCOMED PHARMACEUTICALS INC | Director of Finance/CFO | 2014-03-30 |
Ilypsa, Inc.
 Ilypsa, Inc. BiotechnologyHealth Technology Ilypsa, Inc. operates a biopharmaceutical firm. It develops renal care pharmaceutical products. The company was founded on March 6, 2003 and is headquartered in Thousand Oaks, CA. | Director of Finance/CFO | 2007-08-31 |
Training of William Waddill
| University of Illinois | Undergraduate Degree |
Experiences
Positions held
Connections
1st degree connections
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
| Listed companies | 6 |
|---|---|
| ARROWHEAD PHARMACEUTICALS, INC. | Health Technology |
| EXELIXIS, INC. | Health Technology |
| CALITHERA BIOSCIENCES, INC. | Health Technology |
| PROTAGONIST THERAPEUTICS, INC. | Health Technology |
| ANNEXON, INC. | Health Technology |
| TURNSTONE BIOLOGICS CORP. | Health Technology |
| Private companies | 9 |
|---|---|
PricewaterhouseCoopers LLP
 PricewaterhouseCoopers LLP Miscellaneous Commercial ServicesCommercial Services PricewaterhouseCoopers LLC provides assurance, tax and advisory services. Its services include audit and assurance, consulting, deals, human resources, legal, tax, and family business. The firm also offers accountability, risk management, structuring, mergers and acquisitions, and performance and process improvement. The company was founded in 1998 and is headquartered in Buffalo, NY. | Commercial Services |
OncoMed Pharmaceuticals, Inc.
 OncoMed Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology OncoMed Pharmaceuticals, Inc. operates as a clinical stage biopharmaceutical company, which focuses on discovering and developing novel therapeutics for cancer's growth, resistance, recurrence and metastasis. The company was founded by Michael F. Clarke and Max Wicha in August 2004 and is headquartered in Redwood City, CA. | Health Technology |
Ilypsa, Inc.
Ilypsa, Inc. BiotechnologyHealth Technology Ilypsa, Inc. operates a biopharmaceutical firm. It develops renal care pharmaceutical products. The company was founded on March 6, 2003 and is headquartered in Thousand Oaks, CA. | Health Technology |
Deloitte & Touche, Inc.
 Deloitte & Touche, Inc. Miscellaneous Commercial ServicesCommercial Services Part of Deloitte LLP (New York), Deloitte & Touche, Inc. provides accounting services. The company is based in Calgary, Canada. | Commercial Services |
The Association of Bioscience Financial Officers
 The Association of Bioscience Financial Officers Miscellaneous Commercial ServicesCommercial Services The Association of Bioscience Financial Officers operates as a national networking group for biotechnology, med tech and bioscience financial officers. The company was founded in 1988 and is headquartered in Menlo Park, CA. | Commercial Services |
Biotechnology Innovation Organization
 Biotechnology Innovation Organization Miscellaneous Commercial ServicesCommercial Services Biotechnology Innovation Organization is the world's biotechnology organization, providing advocacy, business development and communications services for more than 1,200 members worldwide. BIO members are involved in the research and development of innovative healthcare, agricultural, industrial and environmental biotechnology technologies. Corporate members range from entrepreneurial companies developing a first product to Fortune 100 multinationals. also represent state and regional biotech associations, service providers to the industry and academic centers. | Commercial Services |
Sorbent Therapeutics, Inc.
 Sorbent Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Sorbent Therapeutics, Inc. develops therapies for cardiovascular and renal diseases. It focuses on the development of non-absorbed polymeric drugs to satisfy unmet clinical needs in large cardiovascular and renal markets such as heart failure, chronic kidney disease and hypertension. The company was founded by William R. Rajski, Dean Abrassart, Donald W. Joseph and Lee W. Henderson on January 25, 2005 and is headquartered in Sunnyvale, CA. | Health Technology |
Protagonist Pty Ltd.
Protagonist Pty Ltd. Pharmaceuticals: MajorHealth Technology Protagonist Pty Ltd. operates as a clinical-stage biopharmaceutical company. Its proprietary technology platform focused on discovering and developing peptide-based new chemical entities to address significant unmet medical needs. The company was founded on September 19, 2001 and is headquartered in Brisbane, Australia. | Health Technology |
| Annexon Biosciences, Inc. |
- Stock Market
- Insiders
- William Waddill
